リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「慢性閉塞性肺疾患患者の増悪のセルフモニタリングに関する質問紙の開発と予備的検討」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

慢性閉塞性肺疾患患者の増悪のセルフモニタリングに関する質問紙の開発と予備的検討

Matsumoto, Mari 松本, 麻里 マツモト, マリ 神戸大学

2020.03.25

概要

This study aimed to develop a questionnaire assessing patients’ self-monitoring of exacerbations of chronic obstructive pulmonary disease (QASM-ECOPD) and model the causal relationships of its factors using structural equation modeling. The QASM-ECOPD was divided into domain 1, “awareness of exacerbations,” and domain 2, “interpreting symptoms and signs as cues to seek medical care.” Factor analysis showed that domain 1 comprised 22 items across 3 factors and domain 2 comprised 18 items across 3 factors. Confirmatory factor analysis showed that the two domains had reasonable model fit. The internal consistency and stability were at an acceptable level. The QASM-ECOPD correlated with the score of external criterion. The structural model of QASM-ECOPD exhibited a sequential relationship between the factors and the fact that a domain 2 factor, “recognizing hesitation before seeking medical care” is at its basis. COPD patients showed reluctance to seek treatments, and even if they noticed the onset of signs, they did not take action to seek medical care until general symptoms appeared. The QASM-ECOPD is reliable and valid to assess patients’ self-monitoring of exacerbation. The structural model of QASMECOPD provides important suggestions for encouraging COPD patients to take action to seek medical care in early stages of exacerbation.

参考文献

1) Almagro P, Calbo E, Ochoa de Echagüen A, et al. Mortality after hospitalization for COPD. Chest 121: 1441–1448, 2002.

2) Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 124: 459–467, 2003.

3) Soler-Cataluña JJ, Martínez-García MA, Román Sánchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 60: 925–931, 2005. DOI: 10.1136/thx.2005.040527

4) Donaldson GC, Seemungal TA, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 57: 847–852, 2002.

5) Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 157: 1418–1422, 1998. DOI: 10.1164/ajrccm.157.5.9709032

6) Spencer S, Calverley PM, Burge PS, et al. Impact of preventing exacerbations on deterioration of health status in COPD. European Respiratory Journal 23: 698–702, 2004.

7) Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and costs of chronic obstructive pulmonary disease. European Respiratory Journal 27: 188–207, 2006. DOI: 10.1183/09031936.06.00024505

8) Wilkinson TM, Donaldson GC, Hurst JR, et al. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 169: 1298–1303, 2004. DOI: 10.1164/rccm.200310-1443OC

9) Lenferink A, Brusse-Keizer M, van der Valk PDLPM, et al. Self-management interventions including action plans for exacerbation versus usual care in patients with chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews Library (8), 2017. DOI: 10.1002/14651858.CD011682,pub2.

10) Howcroft M, Walters EH, Wood-Baker R, et al. Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews Library (12), 2016. DOI: 10.1002/14651858.CD005074,pub4.

11) Bischoff EWMA, Hamd DH, Sedeno M, et al. Effects of written action plan adherence on COPD exacerbation recovery. Thorax 66: 26–31, 2011. DOI: 10.1136/thx.2009.127621

12) Bucknall CE, Miller G, Lloyd SM, et al. Glasgow supported self-management trial (GSuST) for patients with moderate to severe COPD: Randomized controlled trial. BMJ 344: e1060, 2012. DOI: 10.1136/bmj.e1060

13) Korpershoek YJG, Vervoort SCJM, Nijssen LIT, et al. Factors influencing exacerbation-related selfmanagement in patients with COPD: A qualitative study. International Journal of COPD 11: 2977– 2990, 2016. DOI: 10.2147/COPD.S116196

14) Adams R, Chavannes N, Jones K, et al. Exacerbations of chronic obstructive pulmonary disease--a patients' perspective. Primary Care Respiratory Journal 15: 102–109, 2006. DOI: 10.1016/j.pcrj.2006.01.003

15) Williams V, Hardinge M, Ryan S, et al. Patients' experience of identifying and managing exacerbations in COPD: A qualitative study. NPJ Primary Care Respiratory Medicine 24: 14062, 2014. DOI: 10.1038/npjpcrm.2014.62

16) Larson P, Uchinuno A, Isumi S, et al. An integrated approach to symptom management. Nursing & Health Sciences 1: 203–210, 1999.

17) Wilde MH, Garvin S. A concept analysis of self-monitoring. Journal of Advanced Nursing 57: 339– 350, 2006. DOI: 10.1111/j.1365-2648.2006.04089.x

18) Song M, Lipman TH. Concept analysis: Self-monitoring in type 2 diabetes mellitus. International Journal of Nursing Studies 45: 1700–1710, 2008. DOI: 10.1016/j.ijnurstu.2008.04.005

19) Karloh M, Mayer AF, Maurici R, et al. The COPD Assessment Test: What do we know so far? A systematic review and meta-analysis about clinical outcomes prediction and classification of patients into gold stages. Chest 149: 413–425, 2016. DOI: 10.1378/chest.15-1752

20) Leidy NK, Wilcox TK, Jones PW, et al. Development of the EXAcerbations of chronic obstructive pulmonary disease tool (EXACT): A patient-reported outcome (PRO) measure. Value Health 13: 965– 975, 2010. DOI: 10.1111/j.1524-4733.2010.00772.x

21) Fayers PM, Machin D. Principles of measurement scales. (In) Quality of Life: The Assessment Analysis, and Interpretation of Patient-Reported Outcomes (2nd ed). Fayers PM, Machin D. (Eds.) Chichester, West Sussex: John Wiley & Sons Ltd, pp. 28–42, 2000.

22) Gorsuch RL. Factor analysis (2nd ed). Hillsdale, Michigan: Lawrence Erlbaum Associates, 1983.

23) Honjo K. [Revised Self-care Agency Questionnaire for nursing practice and utilization method.] Nursing Today 25: 21–25, 2010. (in Japanese)

24) Polit DF, Beck CT. Developing and testing self-report questionnaires. (In) Nursing research: Generating and assessing evidence for nursing practice (8th ed) Polit DF, Beck CT. (Eds.), Philadelphia, PA: Lippincott Williams & Wilkins. pp. 474–505, 2008.

25) Hu LT, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Structural Equation Modeling 6: 1–55, 1999.

26) Steiger JH. Understanding the limitations of global fit assessment in structural equation modeling. Personality and Individual Differences 42: 893–898, 2007. DOI: 10.1016/j.paid.2006.09.017

27) Fayers PM, Machin D. Scores and measurements: validity, reliability, sensitivity. (In) Quality of Life: The Assessment Analysis, and Interpretation of Patient-Reported Outcomes (2nd ed.). Fayers PM, Machin D. (Eds.) Chichester, West Sussex: John Wiley & Sons Ltd, pp. 45–71, 2000.

28) Miravitlles M, Anzueto A, Legnani D, et al. Patient's perception of exacerbations of COPD--the PERCEIVE study. Respiratory Medicine 101: 453–460, 2007. DOI: 10.1016/j.rmed.2006.07.010

29) Gysel M, Higginson IJ. Access to services for patients with chronic obstructive pulmonary disease: The invisibility of breathlessness. Journal of Pain and Symptom Management, 36, 451–460, 2008. DOI: 10.1016/j.jpainsymman.2007.11.008

30) Kessler R, Ståhl E, Vogelmeier C, et al. Patient understanding, detection, and experience of COPD exacerbations: an observational, interview-based study. Chest, 130, 133–142, 2006. DOI: 10.1378?chest.130.1.133

31) Seemungal TA, Donaldson GC, Bhowmik AB, et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 161: 1608–1613, 2000. DOI: 10.1164/ajrccm.161.5.9908022

参考文献をもっと見る